FR2219154B1 - - Google Patents

Info

Publication number
FR2219154B1
FR2219154B1 FR7405621A FR7405621A FR2219154B1 FR 2219154 B1 FR2219154 B1 FR 2219154B1 FR 7405621 A FR7405621 A FR 7405621A FR 7405621 A FR7405621 A FR 7405621A FR 2219154 B1 FR2219154 B1 FR 2219154B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7405621A
Other versions
FR2219154A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2219154A1 publication Critical patent/FR2219154A1/fr
Application granted granted Critical
Publication of FR2219154B1 publication Critical patent/FR2219154B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7405621A 1973-02-23 1974-02-19 Expired FR2219154B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2254473A JPS5714337B2 (fr) 1973-02-23 1973-02-23

Publications (2)

Publication Number Publication Date
FR2219154A1 FR2219154A1 (fr) 1974-09-20
FR2219154B1 true FR2219154B1 (fr) 1978-01-06

Family

ID=12085750

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7405621A Expired FR2219154B1 (fr) 1973-02-23 1974-02-19

Country Status (15)

Country Link
US (1) US3912705A (fr)
JP (1) JPS5714337B2 (fr)
AT (1) AT335085B (fr)
AU (1) AU475886B2 (fr)
BE (1) BE811467A (fr)
CA (1) CA1032934A (fr)
CH (1) CH594609A5 (fr)
DE (1) DE2408324A1 (fr)
FR (1) FR2219154B1 (fr)
GB (1) GB1434147A (fr)
HK (1) HK15479A (fr)
HU (1) HU170645B (fr)
NL (1) NL7402487A (fr)
NO (1) NO141262C (fr)
SE (1) SE400074B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
NL183764C (nl) * 1974-10-16 1989-01-16 Gruenenthal Gmbh Werkwijze voor de bereiding van een geneesmiddel met psychotrope of neurotrope werking en werkwijze voor de bereiding van een histidylprolineamide-derivaat.
AU504840B2 (en) 1975-09-09 1979-11-01 Takeda Chemical Industries Ltd Medicinal compositions
AU4125578A (en) * 1977-11-09 1979-05-17 Merck & Co Inc Tripeptides
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4426378A (en) 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant
JPS59155346A (ja) * 1983-02-24 1984-09-04 Itsuro Sofue ペプタイド
JPS60190795A (ja) * 1984-03-09 1985-09-28 Takeda Chem Ind Ltd ペプタイド
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
BR112016025076B1 (pt) * 2014-04-30 2022-03-03 Syngenta Participations Ag Processo para a preparação de ciclosserinas substituídas e seus compostos
WO2023232560A1 (fr) * 2022-05-30 2023-12-07 Syngenta Crop Protection Ag Procédé de préparation de 2-oxazolidinones substituées en position 4

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides

Also Published As

Publication number Publication date
GB1434147A (en) 1976-05-05
FR2219154A1 (fr) 1974-09-20
NO141262B (no) 1979-10-29
NO141262C (no) 1980-02-06
DE2408324A1 (de) 1974-08-29
AT335085B (de) 1977-02-25
US3912705A (en) 1975-10-14
JPS5714337B2 (fr) 1982-03-24
CA1032934A (fr) 1978-06-13
AU475886B2 (en) 1976-09-09
CH594609A5 (fr) 1978-01-13
ATA138074A (de) 1976-06-15
HU170645B (fr) 1977-07-28
HK15479A (en) 1979-03-30
JPS49108075A (fr) 1974-10-14
SE400074B (sv) 1978-03-13
NO740546L (no) 1974-08-26
BE811467A (fr) 1974-08-22
AU6584474A (en) 1975-08-21
NL7402487A (fr) 1974-08-27

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU471343B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
JPS5714337B2 (fr)
AR201229Q (fr)
AU466283B2 (fr)
AU472848B2 (fr)
AR199451A1 (fr)
AU461342B2 (fr)
AU471461B2 (fr)
AR195311A1 (fr)
AR195948A1 (fr)
AR210729A1 (fr)
AU447540B2 (fr)
AR196382A1 (fr)
AR197627A1 (fr)
AR200256A1 (fr)
AR200885A1 (fr)
AR201432A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse